Last reviewed · How we verify

Paradione (PARAMETHADIONE)

FDA-approved approved Small molecule Quality 20/100

Paradione (Paramethadione) is a small molecule drug that targets voltage-gated T-type calcium channels. It was originally developed and is currently owned by a company not specified in the provided facts. Paradione is used to treat absence seizures and epilepsy, and was FDA approved in 1949. It is off-patent and has no active Orange Book patents, meaning it is available as a generic medication. However, there are no generic manufacturers listed.

At a glance

Generic namePARAMETHADIONE
Drug classparamethadione
TargetVoltage-gated T-type calcium channel
ModalitySmall molecule
Therapeutic areaNeuroscience
PhaseFDA-approved
First approval1949

Approved indications

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions